FDA Panel Votes to Expand PMA for Hologic, Inc.'s Mammography System

The FDA’s Radiological Devices Panel votes to approve expanded indication for Hologic’s Selenia 3D digital mammography system.

The FDA’s Radiological Devices Panel this week voted to grant Hologic’s (NSDQ:HOLX) expanded approval for its 1st-of-its-kind Selenia Dimensions 3D digital mammography system.

MORE ON THIS TOPIC